首页 / 资料库 / 文献详情

[Accompanied needling at Huantiao (GB30) as an adjunctive therapy for piriformis syndrome: a randomized controlled trial].

Xilan ChangQ Angqiang WangYahong YanQiqu YinFei Shen赵增趁

2026PubMedBiochemistry, Genetics and Molecular Biology被引 1

出版方页面 →

摘要

Objective: To observe the clinical efficacy of accompanied needling at Huantiao (GB30) as an adjunctive therapy for piriformis syndrome (PS). Methods: medial to Huantiao (GB30) were selected. Both groups received treatment once daily, with one treatment course consisting of 5 consecutive days, a total of 2 courses were required, with a 2-day break between courses. Before and after treatment, the score of piriformis muscle symptoms and signs, as well as the pain visual analogue scale (VAS) score were compared in both groups. Musculoskeletal ultrasound was used to assess the thickness of the piriformis muscle before and after treatment in both groups, and clinical efficacy was compared. Results: <0.01). Conclusion: Accompanied needling at Huantiao (GB30) as an adjunctive therapy for PS can effectively alleviate clinical symptoms, improve the structure and function of piriformis muscle.

引用本文(GB/T 7714)

Xilan Chang, Q Angqiang Wang, Yahong Yan, 等. [Accompanied needling at Huantiao (GB30) as an adjunctive therapy for piriformis syndrome: a randomized controlled trial].[J]. PubMed, 2026.

引文网络

参考文献与被引分析加载中…

DOI:https://doi.org/10.13703/j.0255-2930.20250403-k0001

本站仅收录题录与摘要供学习参考,全文版权归属出版方;如有侵权请联系我们删除。